TB/HIV Policy Monitoring & Advocacy Community Perspective - - PowerPoint PPT Presentation

tb hiv policy monitoring advocacy community perspective
SMART_READER_LITE
LIVE PREVIEW

TB/HIV Policy Monitoring & Advocacy Community Perspective - - PowerPoint PPT Presentation

TB/HIV Policy Monitoring & Advocacy Community Perspective Tamari Trapaidze Welfare Foundation, Georgia 28 May 2009 Georgia a country in Eastern Europe with a high Georgia a country in Eastern Europe with a high prevalence of TB


slide-1
SLIDE 1

TB/HIV Policy Monitoring & Advocacy Community Perspective

Tamari Trapaidze Welfare Foundation, Georgia 28 May 2009

slide-2
SLIDE 2
  • Georgia a country in Eastern Europe with a high

Georgia a country in Eastern Europe with a high prevalence of TB infection and relatively low prevalence of TB infection and relatively low prevalence of HIV/AIDS (with adult HIV prevalence of HIV/AIDS (with adult HIV prevalence 0.2%, WHO 2006 prevalence 0.2%, WHO 2006 ) )

  • Tuberculosis is one of the leading causes of

Tuberculosis is one of the leading causes of morbidity in Georgia. TB morbidity in Georgia. TB – – previously previously considered as considered as “ “disease that belongs to history disease that belongs to history” ”, , has reached dramatic figures during the last two has reached dramatic figures during the last two decades. decades.

slide-3
SLIDE 3

14 settings with ≥ 6% MDR-TB among new cases 2002-2007

5 10 15 20 25 30 Georgia Heilongjiang Province, China Inner Mongolia Autonomous Region, China Orel Oblast, RF Armenia Lithuania Latvia Mary El Oblast, RF Estonia Tashkent, Uzbekistan Tomsk Oblast, RF Donetsk Oblast, Ukraine Republic of Moldova Baku City, Azerbaijan WHO/IUATLD Global Report on Anti-tuberculosis drug resistance in the world 2008

slide-4
SLIDE 4

13 settings with >30% resistance to any TB drug among new cases 2002-2007

5 10 15 20 25 30 35 40 45 50 55 60 65 70 Viet Nam Jordan Guatemala Inner Mongolia Autonomous Region, China Tomsk Oblast, RF Latvia Armenia Heilongjiang Province, China Donetsk Oblast, Ukraine Republic of Moldova Georgia Tashkent, Uzbekistan Baku City, Azerbaijan

WHO/IUATLD Global Report on Anti-tuberculosis drug resistance in the world 2008

slide-5
SLIDE 5

16 settings with ≥ 25% MDR-TB among previously treated cases 2002-2007

10 20 30 40 50 60 70 80 Guatemala Georgia Czech Republic Heilongjiang Province, China Thailand Latvia Oman Jordan Armenia Inner Mongolia Autonomous Region, China Donetsk Oblast, Ukraine Lithuania Republic of Moldova Estonia Baku City, Azerbaijan Tashkent, Uzbekistan WHO/IUATLD Global Report on Anti-tuberculosis drug resistance in the world 2008

slide-6
SLIDE 6

TB Monitoring, Research, Advocacy – community perspective

Based on 2 projects of Welfare Foundation

TB/HIV coinfection Monitoring and Advocacy Decreasing burden of Tuberculosis by

contributing to building and empowerment of TB communities of women and other vulnerable groups in Adjara region of Georgia

slide-7
SLIDE 7

TB/HIV coinfection Monitoring and Advocacy

In 2006, NGOs from 12 countries, including In 2006, NGOs from 12 countries, including Georgia, were given funding and training from Georgia, were given funding and training from Public Health Watch/OSI and TAG to conduct a Public Health Watch/OSI and TAG to conduct a monitoring and advocacy project to assess the monitoring and advocacy project to assess the extent of TB/HIV collaborative activities in the extent of TB/HIV collaborative activities in the respective countries. respective countries.

slide-8
SLIDE 8

Project mission

To increase civil society engagement in policymaking efforts around the adoption and implementation of WHO collaborative TB/HIV activities. Two phases Two phases – – Monitoring followed with Monitoring followed with Advocacy Advocacy

slide-9
SLIDE 9

Monitoring phase key Monitoring phase key-

  • findings

findings

  • TB/HIV collaborative activities in Georgia are improving, howeve

TB/HIV collaborative activities in Georgia are improving, however r practical collaboration still very little; practical collaboration still very little;

  • No meaningful involvement of people affected/infected with these

No meaningful involvement of people affected/infected with these two two diseases diseases

  • No data submission to National TB and HIV bodies being requested

No data submission to National TB and HIV bodies being requested from the private medical sector (labs, doctors); from the private medical sector (labs, doctors);

  • Lack of Government

Lack of Government’ ’s accountability towards public in general, lack of s accountability towards public in general, lack of transparency; transparency;

  • Poor public awareness on TB/HIV

Poor public awareness on TB/HIV

  • TB drugs (all 1-st line and some 2-nd) sold prescription-free in

pharmacies; no effective regulations prohibiting selling TB (as well as other) antibiotics;

slide-10
SLIDE 10

Advocacy Target

To secure new policy guidelines against the availability of prescription free TB antibiotics in Georgia.

slide-11
SLIDE 11

Three approaches to advocacy

Advocacy can be done… those affected by the situation.

slide-12
SLIDE 12

Objectives Objectives

To raise awareness and secure support from civil

society (NGOs, affected communities, CBOs, Media);

To gain support from health care providers of TB and

HIV/AIDS services to convince the authorities;

To engage in dialogue with decision makers from the

MoLHSA about the consequences of accessing prescription free TB antibiotics.

slide-13
SLIDE 13

Target audience

Primary target audience: Policy makers (decision

makers) from the MoLHSA, Parliamentary health committee;

Secondary target audiences: TB and HIV health

care providers; affected communities with TB and HIV/AIDS; Civil society organizations.

slide-14
SLIDE 14

Key Advocacy Interventions

Overall Problem Analysis Development of strong, persuasive materials (reports,

bulletins, advocacy documents);

Treatment literacy +Patient Charter on tuberculosis

(about patients’ rights and responsibilities);

Expert panel meetings with health care providers of TB

and HIV/AIDS services;

Roundtable working meetings with representatives of the

MoLHSA and Parliamentary health committee.

slide-15
SLIDE 15

Advocacy conference

Important tool to bringing together all stakeholders related to TB; To create a platform for “TB support team” having TB champions as a role models, to reduce stigma related to TB;

Photo

Photo

slide-16
SLIDE 16

Advocacy conference

To present analytical paper describing “best-

practices” of countries which once faced problem of prescription-free antibiotics;

To increase political support for TB and

TB/HIV on national level;

Jointly discuss necessary steps for moving to

adoption of the most appropriate way of restriction availability of TB antibiotics (letter prepared for the MoLHSA and follow up…)

slide-17
SLIDE 17

Achievements

TB/HIV issues included in national curriculum

for general practitioners

Parliamentary Health Committee initiative to

work on the law introducing prohibition of prescription free practice of TB antibiotics

slide-18
SLIDE 18

Decreasing burden of Tuberculosis by contributing to building and empowerment of TB communities of women and other vulnerable groups in Adjara region of Georgia

slide-19
SLIDE 19

Barriers to TB control

Project target area - remote isolated mountainous

area; widespread rural poverty; limited financial and physical access to health care;

place inhabited by Muslim ethnic Georgians;

Differences in the household and community roles;

Gender inequalities - females tend to be restricted to

the community around the home, women’s access to health care is often limited and differ;

High prevalence and incidence rates of Tuberculosis

and significant number of IDPs

Health awareness among the local population is low.

slide-20
SLIDE 20

ACSM approaches

Meaningful engagement of community is vital for

achieving long-term goals of decrease TB problem;

WF supports development of local communities in

regions, engaging affected women (close collaboration with the local NGOs and community activists; recruitment of 10 women - community activists, building their capacity )

Building a TB community - not just about creating equal

patient-clinician relationships, government authorities also need to change their attitudes to view NGOs as partners.

slide-21
SLIDE 21

Lessons learned Lessons learned

  • Direct experience has real value;

Direct experience has real value;

  • Citizen monitors are independent

Citizen monitors are independent – – can say things that can say things that bureaucrats can bureaucrats can’ ’t say t say

  • Importance of establishing credibility trough familiarizing

Importance of establishing credibility trough familiarizing

  • urselves with technical vocabulary/concepts;
  • urselves with technical vocabulary/concepts;
  • Importance of striking constructive tone (acknowledging

Importance of striking constructive tone (acknowledging progress/positive steps as well as weaknesses; development and progress/positive steps as well as weaknesses; development and follow up with recommendations) follow up with recommendations)

  • Constructive critique leads to better, more efficient and

Constructive critique leads to better, more efficient and effective policies and services; effective policies and services;

  • Importance of convincing arguments and proposition of

Importance of convincing arguments and proposition of solution of the problem; solution of the problem;

  • Public engagement contributes to greater governmental

Public engagement contributes to greater governmental accountability accountability

slide-22
SLIDE 22

LASTING CHANGE

= + +

mass attitudes and beliefs that also sustain change (and sometimes are the change) credible arguments sufficiently broad and intense support convinced decision makers an infrastructure/capacity that sustains change

slide-23
SLIDE 23

Thank you!